Stenosis News and Research

RSS

A stenosis is an abnormal narrowing in a blood vessel or other tubular organ or structure.

U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis

The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves.

14 Mar 2011

Medtronic launches VERTEX SELECT CHROMALOY Plus Rods in the U.S.

Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. today announced the U.S. launch of VERTEX SELECT CHROMALOY Plus Rods.

10 Mar 2011

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

10 Mar 2011

Vertos reports long-term safety and efficacy of mild in patients with LSS

Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections for treating lumbar spinal stenosis.

8 Mar 2011

CAS is an economically attractive alternative to endarterectomy for stroke patients

Researchers determined that carotid artery stenting with embolic protection is an economically attractive alternative to endarterectomy for patients at increased surgical risk.

3 Mar 2011

DMC CVI completes the first two transcatheter aortic valve implants in Michigan

The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has completed the first two transcatheter aortic valve implants (TAVI) ever achieved in Michigan. The procedures are a part of CVI's participation in the Medtronic CoreValve® U.S. Clinical Trial. This multi-state trial will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis.

2 Mar 2011

Takeda receives FDA approval for EDARBI to treat hypertension in adults

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved EDARBI for the treatment of hypertension, or high blood pressure, in adults.

27 Feb 2011

InfraReDx to showcase LipiScan IVUS Coronary Imaging System at CRT 2011

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced that its LipiScan™ IVUS Coronary Imaging System will be featured in several presentations during the annual Cardiovascular Research Technologies (CRT) 2011 meeting, being held February 27 through March 1, 2011 at the Omni Shoreham Hotel in Washington, D.C.

24 Feb 2011

Investigational heart valve implanted in patient through small puncture hole in leg

Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.

21 Feb 2011

Positive results from Medtronic CoreValve System study for treatment of aortic valve disease

Medtronic, Inc. today issued a statement on results from an independent study published online in the journal Circulation, which confirmed both early and sustained clinical benefits for patients receiving the Medtronic CoreValve® System for the treatment of aortic valve disease.

19 Feb 2011

IQWiG publishes results of search update for evidence-based clinical practice guidelines on CHD

On 7 February 2011, the German Institute for Quality and Efficiency in Health Care published the results of a search update for evidence-based clinical practice guidelines on coronary heart disease.

17 Feb 2011

Cappella Medical presents new clinical data on Sideguard coronary sidebranch system at International JIM 2011

Cappella Medical Devices presented new clinical data on its unique Sideguard® coronary sidebranch system today at the International JIM 2011 in Rome, Italy.

11 Feb 2011

Sorin's 2010 consolidated revenues increase 4.9% to € 745.8 million

The Board of Directors of Sorin S.p.A. meeting today under the chairmanship of Rosario Bifulco reviewed the fourth quarter 2010 and the preliminary 2010 consolidated results.

11 Feb 2011

Rcadia receives FDA 510(k) clearance for enhanced COR Analyzer System to assess coronary branch vessels

Rcadia Medical Imaging announced today that it has received FDA 510(k) marketing clearance for an enhanced version of its COR Analyzer® System to assess coronary branch vessels in addition to main coronary arteries in patients with suspected coronary artery disease (CAD).

10 Feb 2011

Researchers receive NIH grant to develop computer models for pediatric airway problems

A multidisciplinary team of University of North Carolina at Chapel Hill researchers has been awarded a $3.6 million grant to develop computer models that will allow physicians to predict which treatments will work best in children with upper airway problems.

4 Feb 2011

NeuroMetrix fourth quarter total revenues decrease to $3.1 million

NeuroMetrix, Inc., a science-based health care company transforming patient care through neurotechnology, today reported business and financial highlights for the quarter and year ended December 31, 2010.

3 Feb 2011

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Merck announced today that data from the pivotal Phase III study with GARDASIL in males were published in the February 3 issue of the New England Journal of Medicine.

3 Feb 2011

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces the commercial availability in Europe of the self- anchoring Perceval S aortic heart valve. The innovative next-generation valve represents the latest innovation in heart valve technology.

31 Jan 2011

Medtronic releases CD HORIZON SOLERA Spinal System in the U.S.

Continuing a stream of recent advancements for stabilization of the spine, Medtronic, today announced both the release of its CD HORIZON SOLERA Spinal System in the U.S. and a limited market release in Japan.

27 Jan 2011

Mount Sinai's Cardiac Catheterization Lab wins New York State's highest 'two-star' safety rating

Mount Sinai's Cardiac Catheterization Laboratory has been awarded New York State's highest "two-star" safety rating in every category of case the state tracks for percutaneous coronary intervention, according to new data released this month that examine patient discharges from 2006 - 2008.